Shaanxi Kanghui Pharm Co Ltd (603139) — Capital Reinvestment Ratio
Shaanxi Kanghui Pharm Co Ltd (603139) has a Capital Reinvestment Ratio of 3.44x as of September 2025, meaning it reinvests 3% of its operating cash flow (CN¥7.14 Million) in capital expenditures (CN¥24.57 Million). See Shaanxi Kanghui Pharm Co Ltd (603139) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shaanxi Kanghui Pharm Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Shaanxi Kanghui Pharm Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check 603139 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shaanxi Kanghui Pharm Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Shaanxi Kanghui Pharm Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see 603139 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.25x | CN¥37.29 Million | CN¥46.66 Million | ▼ -54.3% |
| 2022 | 2.74x | CN¥50.43 Million | CN¥138.13 Million | ▼ -93.0% |
| 2021 | 39.13x | CN¥7.42 Million | CN¥290.30 Million | ▲ +1295.1% |
| 2020 | 2.80x | CN¥93.72 Million | CN¥262.89 Million | ▲ +270.3% |
| 2019 | 0.76x | CN¥107.53 Million | CN¥81.45 Million | ▲ +750.0% |
| 2018 | 0.09x | CN¥62.64 Million | CN¥5.58 Million | ▲ +8.2% |
| 2017 | 0.08x | CN¥43.60 Million | CN¥3.59 Million | ▲ +22.9% |
| 2016 | 0.07x | CN¥71.72 Million | CN¥4.81 Million | ▼ -84.8% |
| 2015 | 0.44x | CN¥28.50 Million | CN¥12.60 Million | ▼ -48.0% |
| 2014 | 0.85x | CN¥22.72 Million | CN¥19.30 Million | ▼ -34.2% |
| 2013 | 1.29x | CN¥39.35 Million | CN¥50.77 Million | ▲ +86.3% |
| 2012 | 0.69x | CN¥16.12 Million | CN¥11.17 Million | — |